# Docetaxel Lipid Microsphere (DT-LM) for Injection in Chemotherapy Patients

> **NCT01611961** · PHASE1 · UNKNOWN · sponsor: **Shenyang Pharmaceutical University** · enrollment: 35 (estimated)

## Conditions studied

- Advanced Cancer

## Interventions

- **DRUG:** DT-LM
- **DRUG:** docetaxel

## Key facts

- **NCT ID:** NCT01611961
- **Lead sponsor:** Shenyang Pharmaceutical University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-08
- **Primary completion:** 2014-09
- **Final completion:** 2014-12
- **Target enrollment:** 35 (ESTIMATED)
- **Last updated:** 2014-09-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01611961

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01611961, "Docetaxel Lipid Microsphere (DT-LM) for Injection in Chemotherapy Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01611961. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*